Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Shareholder Meeting Date to Approve the Business fusion

Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Shareholder Meeting Date to Approve the Business fusion

Forward-Looking Statements

This pr release contains, and particular dental statements produced by representatives of Tenzing and Reviva and their particular affiliates, every once in awhile may contain, “forward-looking statements” within this is associated with the harbor” that is“safe regarding the Private Securities Litigation Reform Act. Tenzing’s and Reviva’s results that are actual vary from their expectations, quotes and projections and therefore, you shouldn’t depend on these forward-looking statements as predictions of future activities. Terms such as for example “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “might” and “continues,” and comparable expressions are designed to determine such statements that are forward-looking. These forward-looking statements consist of, without limitation, Tenzing’s and Reviva’s objectives with regards to future performance and expected financial effects for the company mix, the satisfaction regarding the closing conditions into the company mix in addition to timing associated with conclusion associated with company mix. These forward-looking statements include significant dangers and uncertainties that may cause real leads to vary materially from anticipated outcomes. These types of facets are outside of the control of Tenzing or Reviva and therefore are tough to anticipate. Facets that could cause such distinctions consist of, but are not restricted to: (1) the event of any occasion, modification or other circumstances that may bring about the termination associated with the merger contract for the business enterprise blend (the “Merger Agreement”); (2) the failure to perform the business enterprise mix, including due to failure to obtain approval of this investors of Tenzing or other conditions to closing in the Merger contract; (3) the shortcoming to have or keep up with the report on Tenzing’s typical stock on NASDAQ after the company Combination; (4) the danger that the Business fusion disrupts present plans and operations of Reviva as a consequence of the statement and consummation regarding the Business mix; (5) the capacity to recognize the expected advantages of the business enterprise mix, which can be impacted by, among other activities, competition, the capability for the combined business to develop and handle development economically and employ and retain key workers; (6) the potential risks that Reviva’s services and products in development fail clinical trials or aren’t authorized because of the U.S. Food and Drug management or any other relevant authorities; (7) costs related to your company Combination; (8) alterations in applicable laws and regulations or laws; (9) the chance that Tenzing or Reviva might be adversely afflicted with other financial, company, and/or competitive facets; and (10) other dangers and uncertainties identified into the Proxy Statement, including those under “Risk Facets” therein, as well as in other filings because of the Securities and Exchange Commission (“SEC”) produced by Tenzing. The foregoing go now range of facets is maybe perhaps not exclusive. Visitors are cautioned never to put undue reliance upon any forward-looking statements, which talk just at the time of the date made. Neither Tenzing nor Reviva undertakes or takes any responsibility or undertaking to produce publicly any updates or revisions to virtually any forward-looking statements to mirror any improvement in its objectives or any improvement in occasions, conditions or circumstances upon which such declaration is situated, susceptible to law that is applicable.

No Offer or Solicitation

This pr release is actually for informational purposes just and shall perhaps perhaps perhaps perhaps not represent an offer to market or even the solicitation of an offer to get any securities pursuant to your proposed Business fusion or perhaps, nor shall there be any purchase of securities in just about any jurisdiction where the offer, solicitation or purchase will be illegal before the enrollment or certification beneath the securities laws and regulations of every jurisdiction that is such. No offer of securities will be made except in the shape of a prospectus conference what’s needed of area 10 for the Securities Act, as amended.

Bài viết liên quan